Ionela Mihaela V.
- Country
- Romania
- Department
- N/A
Research Overview
- Efficacy and Safety of MET097 in Adults with Overweight or Obesity: A Phase 3, Randomized, Placebo-Controlled Trial
- Phase 3 Randomized, Placebo‑Controlled Trial Assessing Efficacy and Safety of MET097, a Long‑Acting GLP‑1 Receptor Agonist, in Overweight/Obese Adults with Type 2 Diabetes
- Efficacy and safety of subcutaneous once-weekly zenagamtide in participants with overweight or obesity and type 2 diabetes
Data & Insights
Has run more than one trial at 101 of 284 partner sites.
Specializations
Metabolic Health
The investigator specializes in weight management therapeutics and obesity treatment, focusing on innovative approaches to address weight-related health challenges.
- Weight Management Programs
- Obesity Treatment
- Metabolic Disorders
The research interest extends to exploring therapeutic interventions in combination with lifestyle modifications for optimal patient outcomes.
Lifestyle Medicine
Expertise in integrating lifestyle interventions with medical treatments, particularly focusing on dietary management and physical activity protocols.
- Caloric Modification Strategies
- Physical Activity Programs
- Behavioral Interventions
The investigator emphasizes comprehensive approaches that combine medical interventions with lifestyle modifications.
Comorbidity Management
Specialized focus on treating obesity-related comorbidities and developing therapeutic strategies for patients with multiple health conditions.
- Weight-Related Health Complications
- Metabolic Syndrome
- Chronic Disease Management
The investigator addresses complex medical cases involving weight-related health complications and associated conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.